22.05.2025 • NewsBacheminvestmentOligonucleotides

Bachem Expands Multi-Site Production Capacities

The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK, and Switzerland.

Bachem facility
Bachem has announced major investments across their site network, with new funding to improve production facilities at their Bubendorf, Vista, and St Helens sites, along with a new site in Sisseln.
© Bachem

The expansion plans respond to the growing demand for peptides and oligonucleotides therapeutics. With the global market for obesity drugs expected to increase by more than 15-fold by 2030, Bachem continues to scale operations in line with rising demand.

Stepping up Large-Scale Peptide Production at Bubendorf

At its Bubendorf site, Bachem is expanding its large-scale operations with a new state-of-the-art production facility known as Building K.

The building incorporates high-capacity production cells for scalable synthesis, advanced energy systems (heating, cooling, water, cold storage, etc.), and a specialized tank farm for large-scale operations.

Increased Capacities at Vista Site

At their Vista site, Bachem has directed funding to increase annual peptide production capacity to nearly one metric ton.

New features will include:

  • Large-scale SPPS reactors for efficient peptide synthesis.
  • Cleavage equipment train with two filter dryers to enhance throughput.
  • Increased tank farm & waste management to support high-volume operations.
  • Automated glass washer & new heating/chilling systems for operational efficiency.

Increasing Production for Diagnostic Peptides at UK Site & Plans for New Sisseln Site

Improvements to Bachem’s St Helens site infrastructure have resulted in a doubling of output, with a focus on the development of research chemicals. Separately, a new site at Sisseln is being developed in northwestern Switzerland, with concept designs underway.

Company

Logo:

Bachem

Hauptstr. 144
4416 Bubendorf
Switzerland

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.